Table 1

Characteristics of 49 patients who received apomorphine therapy for >2 months

Continuous infusion (n=25)Intermittent injection (n=24)
Age (y)64.7 (6.8)58.9 (9.7)
Duration of disease (y)1-150 16.0 (6–27)11.5 (3–25)
Duration of levodopa therapy (y)1-150 14.0 (5–23)10.0 (3–23)
Duration of “on-off” fluctuations (y)1-150 9.0 (2–19)4.0 (1–18)
Duration of apomorphine therapy (months)44.0 (3–67)22.0 (6–54)
  • Except for “age” (where mean (SD) are shown) data represent median (range).

  • 1-150 At inclusion in study.